Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review-Reference-Cited by-同舟云学术

Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review

Published:2020-09 Issue:3 Volume:56 Page:106072
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Lampejo Temi^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference57 articles.

1. New and improved? A review of novel antibiotics for Gram-positive bacteria;Abbas;Clin Microbiol Infect,2017

2. Lipoglycopeptide antibacterial agents in Gram-positive infections: a comparative review;Van Bambeke;Drugs,2015

3. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin;Guskey;Pharmacotherapy,2010

4. Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens;Das;Ther Adv Infect Dis,2017

5. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus;Saravolatz;J Antimicrob Chemother,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial peptides: Opportunities and challenges in overcoming resistance;Microbiological Research;2024-09

2. New Frontier on Antimicrobial Therapy: Long-Acting Lipoglycopeptides;Pathogens;2024-02-20

3. Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis;International Journal of Infectious Diseases;2024-01

4. Antimicrobial Peptides and Their Applications;Antimicrobial Peptides from Lactic Acid Bacteria;2024

5. Dalbavancin as a treatment option for Rothia aeria endocarditis;Revista Española de Quimioterapia;2023-12-21